BeyondSpring Inc. Proceeds from Long-Term Debt Issued
BeyondSpring Inc. (BYSI) reported Proceeds from Long-Term Debt Issued of $2.99 million for the 6-month period ending 2019-06-30, per its 6-K filed 2019-09-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-09-18
- BeyondSpring Inc. proceeds from issuance of long-term debt for the quarter ending 2019-06-30 was $0.00.
- BeyondSpring Inc. proceeds from issuance of long-term debt for the quarter ending 2019-03-31 was $2.99M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month |
|---|---|---|
| 2019-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2019-09-18 | $2.99M 6-K · filed 2019-09-18 |
| 2019-03-31 | $2.99M 6-K · filed 2019-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |